Arterial Ulcer clinical trials at UCSF
1 research study open to eligible people
Arterial ulcers are a type of sore caused by poor blood flow in the legs. UCSF is recruiting for a clinical trial that involves injecting a growth factor called AMG0001 to help heal these ulcers. The goal is to improve blood flow and ultimately help the ulcers heal faster.
Showing trials for
AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers
open to eligible people ages 18 years and up
This study will assess the safety and efficacy of intramuscular injection of AMG0001 (hepatocyte growth factor [HGF] plasmid) to improve ulcer healing and perfusion in patients with peripheral artery disease.
San Francisco, California and other locations
Our lead scientists for Arterial Ulcer research studies include Michael S Conte, MD.
Last updated: